Jaundice syndrome. Differential management and behavior

Síndrome ictérico. Manejo diferencial y conducta

• Edgardo Mengual-Moreno Universidad de Zulia https://orcid.org/0000-0002-9872-5186

DOI: https://doi.org/10.5281/zenodo.5680028

Keywords: jaundice, cholestasis, liver functionism

Abstract

The jaundice syndrome is a very common disorder characterized by the yellow coloration of the skin and mucosa produced by the elevation of bilirubin, caused by multiple pathologies, which is why it represents an important clinical challenge to be able to orient the triggering cause that allows adequate therapy to be established. In this review, the simplified management algorithm is considered, taking into consideration clinical, laboratory and imaging aspects. The determination of total and fractionated bilirubin as well as the liver functionalism tests alanine aminotransferase, aspartate amino transferase, alkaline phosphatase, gamma glutamyl transpeptidase, are fundamental to establish the predominant biochemical pattern. Imaging studies are critical to determine biliary obstruction. The medical history allows to correlate with the triggering cause.

References

Sticova E, Jirsa M. New insight in bilirrubin metabolism and their clinical implications. World J Gastroenterol 2013;19(38):6398-6407.

Fargo M, Grogan S, Saggui A. Evaluation of Jaundice in adults. Am Fam Physician 2017;95(3)164-168.

Woreta T A, Alqahtani S A. Evaluation of abnormal liver tests. Med Clin North Am. 2014;98(1):1–16

Molina E G, Reddy K R. Postoperative jaundice. Clin Liver Dis. 1999;3(3):477–488.

Erlinger S, Arias I M, Dhumeaux D. Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences. Gastroenterology. 2014;146(7):1625–1638.

Rothschild M A, Oratz M, Schreiber S S. Serum albumin. Hepatology. 1988;8(2):385–401.

Rothschild M A, Oratz M, Zimmon D, Schreiber S S, Weiner I, Van Caneghem A. Albumin synthesis in cirrhotic subjects with ascites studied with carbonate-14C. J Clin Invest. 1969;48(2):344–350.

O'Grady J G, Alexander G J, Hayllar K M, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97(2):439–445.

Wiesner R, Edwards E, Freeman R. et al.Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124(1):91–96.

Pratt DS y Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med . 2000; 342 : 1266-71.

Saini S. Imaging of the hepatobiliary tract. N Engl J Med. 1997; 336: 1889-94, 1997.

Kamath PS. Clinical approach to the patient with abnormal liver test results. Mayo Clin Proc 1996; 71: 1089-1095.